Alexion cautiously steps over to the C6 pathway with an early-stage development deal tied to buyout option
After building up its expertise in the C5 complement pathway through its work on Soliris, Alexion $ALXN is now on a low-budget journey to see …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
